HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism

Oncogene. 2009 Jan 15;28(2):243-56. doi: 10.1038/onc.2008.371. Epub 2008 Oct 13.

Abstract

Cancer cells have complex, unique characteristics that distinguish them from normal cells, such as increased growth rates and evasion of anti-proliferative signals. Global inhibition of class I and II histone deacetylases (HDACs) stops cancer cell proliferation in vitro and has proven effective against cancer in clinical trials, at least in part, through transcriptional reactivation of the p21(WAF1/Cip1)gene. The HDACs that regulate p21(WAF1/Cip1) are not fully identified. Using small interfering RNAs, we found that HDAC4 participates in the repression of p21(WAF1/Cip1) through Sp1/Sp3-, but not p53-binding sites. HDAC4 interacts with Sp1, binds and reduces histone H3 acetylation at the Sp1/Sp3 binding site-rich p21(WAF1/Cip1) proximal promoter, suggesting a key role for Sp1 in HDAC4-mediated repression of p21(WAF1/Cip1). Induction of p21(WAF1/Cip1) mediated by silencing of HDAC4 arrested cancer cell growth in vitro and inhibited tumor growth in an in vivo human glioblastoma model. Thus, HDAC4 could be a useful target for new anti-cancer therapies based on selective inhibition of specific HDACs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Animals
  • Binding Sites
  • Bone Neoplasms / pathology
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / pathology
  • Cell Line, Tumor / metabolism
  • Chick Embryo
  • Cyclin-Dependent Kinase Inhibitor p21 / biosynthesis*
  • Cyclin-Dependent Kinase Inhibitor p21 / genetics
  • Epigenesis, Genetic
  • Gene Expression Regulation, Neoplastic*
  • Gene Knockdown Techniques
  • Glioblastoma / drug therapy
  • Glioblastoma / pathology
  • HeLa Cells / drug effects
  • HeLa Cells / metabolism
  • Histone Deacetylase Inhibitors
  • Histone Deacetylases / physiology*
  • Histones / metabolism
  • Humans
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasm Proteins / physiology*
  • Osteosarcoma / pathology
  • Protein Processing, Post-Translational
  • RNA, Messenger / biosynthesis
  • RNA, Neoplasm / biosynthesis
  • Repressor Proteins / antagonists & inhibitors
  • Repressor Proteins / physiology*
  • Sp1 Transcription Factor / physiology*
  • Tumor Suppressor Protein p53 / antagonists & inhibitors
  • Tumor Suppressor Protein p53 / physiology

Substances

  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Histone Deacetylase Inhibitors
  • Histones
  • Neoplasm Proteins
  • RNA, Messenger
  • RNA, Neoplasm
  • Repressor Proteins
  • Sp1 Transcription Factor
  • Tumor Suppressor Protein p53
  • HDAC4 protein, human
  • Histone Deacetylases